The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
Analysis and Clinical Relevance of Tumor Mutational Burden
A description of TMB as potential biomarker.Read moreRewiring Drug Research and Development through Human Data-Driven Discovery (HD3)
Jackson, D.B. et al. Pharmaceutics 2023, 15(6), 1673Open resourceDetermination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
Mustea, A. et al. Cancers 2023, 15(7), 2053Open resourceCurrently no job listings
Read moreWebinar: IVDR in the laboratory routine – how to make the transition successfully?
On-demand webinarRead moreMH Guide 6.0: Next-level automation and precision in the clinical interpretation of cancer genomic profiling
Press release, 15 February 2023Read moreDaten töten. Den Krebs.
An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)Download articleOvercoming IVDR Challenges – A Webinar on November 8, 2022, at 18:00 CET
On-demand webinarRead moreWebinar: Deepen your knowledge on comprehensive genomic profiling
On-demand webinarRead moreMolecular Health receives IVDR certification for MH Guide
Press release, 13 July 2022Read moreMH Guide Webinar – 07.06.2022 12:00 am EST
On-demand webinarRead moreMH Guide 5.2 – Improved focus. Greater flexibility. Better usability.
Release of MH Guide upgradeRead moreMH Guide Webinar – 28.04.2022 5:00 pm CET
On-demand webinarRead moreMolecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Press release, 10 March 2022Read moreWhat’s new in MH Guide 5.1
Release of MH Guide upgradeRead moreDiscover the benefits of automated variant annotation for your clinical routine
MH Guide interprets complex genetic data quickly and accurately – for the growing challenges of today and tomorrowRead moreApplication of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
Kim, S. et al. Clin Transl Sci. 2022 Jun;15(6):1430-1438. doi: 10.1111/cts.13254Open resourceEvaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
Heydt, C. et al. J. Mol. Pathol. 2022, 3(1), 53-67; https://doi.org/10.3390/jmp3010006Open resourceWhole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms
Brock, S. et al. Front. Mol. Med. 2022, 2:1035290. https://doi.org/10.3389/fmmed.2022.1035290Open resourceThe COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease
Brock, S. et al. Front. Mol. Med. 2022, 2:1035215. https://doi.org/10.3389/fmmed.2022.1035215Open resourceThe earlier, the better – turning data into knowledge
Predisposition analyses of hereditary cancersRead more基因治療計畫的先驅
MH Guide 能夠解讀複雜的分子學分析結果， 協助您為癌症患者提供基於實證的治療建議Read moreGenome-guided treatment decision support for clinical routines
MH Guide Factsheet: From sequencing data to patient report within minutesRead moreUnlocking patient care and therapy breakthroughs from biomedical knowledge
Corporate Factsheet: We make precision medicine a reality for therapy developers, clinicians, and ultimately patientsRead morePathfinder for genome-based therapy planning
MH Guide interprets complex molecular analyses and helps you recommend evidence-based treatments for your cancer patients.Read moreMolecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Press release, 19. October 2021Read moreThe potential of liquid biopsies for early cancer detection powered by ONCOCATCH and MH Guide
Announcing a joint seminarRead moreMH Guide 5.0: Software for therapy planning in precision oncology now available with a comprehensive update
Press release, 30 September 2021Read moreMolecular Health and Korean EONE-Diagnomics Genome Center (EDGC) join forces in liquid biopsy-based precision medicine
Press release, 15 September 2021Read moreA good perspective for your individual cancer therapy
MH Guide helps you and your doctor identify options for treating your diseaseRead moreDiscover what’s new in MH Guide version 5.0
Notes on MH Guide versioning and updatesRead moreMolecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients
Press release, 9 August 2021Read moreKonyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine
Press release, 16 July 2021Read moreWir bringen die biologische Grammatik in die Medizin
Plattform Life Sciences “Smarte Medizin” – Interview with Friedrich von Bohlen (in German)Open resourceTarget adverse event profiles for predictive safety in the postmarket setting
Peter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology & Therapeutics Volume 109, Issue 5, Pages: 1159-1362 (May 2021)Open resourceMH Guide: Molecular tumor diagnostics in 7 steps
An overview of the MH Guide workflow from hotspot to gene profileRead morePanel diagnostics instead of hotspot? Here are the differences
An overview of the pros and cons of using NGS-based panels for molecular tumor profilingRead moreMolecular Health – intelligent solutions for smarter healthcare
NATURE BiopharmaDealmakersOpen resource70-year-old with recurrent ovarian cancer
The story of new hope for an ovarian cancer patient thanks to MH Guide.Read moreMH Guide: six questions and answers
A list of answers to commonly asked questions about tertiary analysis solutions like MH Guide.Read moreMolecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel
Press release, 2 March 2021Read moreMolekulare Diagnostik beim Mammakarzinom – Wo stehen wir auf dem Weg zur molekular stratifizierten Therapie?
ÄrzteZeitung – SpringerMedizin (in German)Open resourceDatenprojekt zu Covid-Langzeitfolgen startet
Handelsblatt (in German)Open resourceWie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern soll
ÄrzteZeitung (in German)Open resourceA case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development
Kim, S. et al. Clin Transl Sci . 2022 Apr;15(4):1003-1013. doi: 10.1111/cts.13219Open resourceAdvancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765Open resource